• Ballestas M E, Chatis P A, Kaye K M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen[J]. Science, 1999, 284(5414): 641-644. doi: 10.1126/science.284.5414.641

  • Belanger C, Gravel A, Tomoiu A. Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fasmediated apoptosis through binding and prevention of procaspase-8 maturation[J]. J Hum Virol, 2001, 4(2): 62-73.

  • Boshoff C, Endo Y, Collins P D. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines[J]. Science, 1997, 278(5336): 290-294. doi: 10.1126/science.278.5336.290

  • Boshoff C, Gao S J, Healy L E. Establishing a KSHV+cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice[J]. Blood, 1998, 91(5): 1671-1679.

  • Brinkmann M M, Glenn M, Rainbow L, et al. 2003.. Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J Virol, 77 (17): 9346-9358.

  • Brinkmann M M, Pietrek M, ttrich-Breiholz O. Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus[J]. J Virol, 2007, 81(1): 42-58. doi: 10.1128/JVI.00648-06

  • Cesarman E, Chang Y, Moore P S. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas[J]. N Engl J Med, 1995, 332(18): 1186-1191. doi: 10.1056/NEJM199505043321802

  • Cesarman E, Moore P S, Rao P H. In vitro establishment and characterization of two acquired immu-nodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpes-virus-like (KSHV) DNA sequences[J]. Blood, 1995, 86(7): 2708-2714.

  • Cesarman E, Nador R G, Bai F. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma[J]. J Virol, 1996, 70(11): 8218-8223.

  • Chang Y, Cesarman E, Pessin M S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma[J]. Science, 1994, 266(5192): 1865-1869. doi: 10.1126/science.7997879

  • Chatterjee M, Osborne J, Bestetti G. Viral IL-6-induced cell proliferation and immune evasion of interferon activity[J]. Science, 2002, 298(5597): 1432-1435. doi: 10.1126/science.1074883

  • Coscoy L, Ganem D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class Ⅰ chains by enhancing their endocytosis[J]. Proc Natl Acad Sci USA, 2000, 97(14): 8051-8056. doi: 10.1073/pnas.140129797

  • Friborg J, Jr Kong W, Hottiger M O. p53 inhibition by the LANA protein of KSHV protects against cell death[J]. Nature, 1999, 402(6764): 889-894.

  • Fujimuro M, Wu F Y, ApRhys C. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency[J]. Nat Med, 2003, 9(3): 300-306. doi: 10.1038/nm829

  • Gaidano G, Capello D, Carbone A. The molecular basis of acquired immunodeficiency syndrome-related lymphomagenesis[J]. Semin Oncol, 2000, 27(4): 431-441.

  • Glenn M, Rainbow L, Aurade F. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus[J]. J Virol, 1999, 73(8): 6953-6963.

  • Gold M R. To make antibodies or not: signaling by the B-cell antigen receptor[J]. Trends Pharmacol Sci, 2002, 23(7): 316-324. doi: 10.1016/S0165-6147(02)02045-X

  • Guasparri I, Keller S A, Cesarman E. KSHV vFLIP is essential for the survival of infected lymphoma cells[J]. J Exp Med, 2004, 199(7): 993-1003. doi: 10.1084/jem.20031467

  • Hamza M S, Reyes R A, Izumiya Y. ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway[J]. J Biol Chem, 2004, 279(37): 38325-38330. doi: 10.1074/jbc.M400964200

  • Inohara N, Gourley T S, Carrio R. Diva, a Bcl-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death[J]. J Biol Chem, 1998, 273(49): 32479-32486. doi: 10.1074/jbc.273.49.32479

  • Ishido S, Wang C, Lee B S. Downregulation of major histocompatibility complex class Ⅰ molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins[J]. J Virol, 2000, 74(11): 5300-5309. doi: 10.1128/JVI.74.11.5300-5309.2000

  • Kakoola D N, Sheldon J, Byabazaire N. Recombination in human herpesvirus-8 strains from Uganda and evolution of the K15 gene[J]. J Gen Virol, 2001, 82(Pt 10): 2393-2404.

  • Kliche S, Nagel W, Kremmer E. Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1[J]. Mol Cell, 2001, 7(4): 833-843. doi: 10.1016/S1097-2765(01)00227-1

  • Knowles D M, Inghirami G, Ubriaco A. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus[J]. Blood, 1989, 73(3): 792-799.

  • Li M, Damania B, Alvarez X. Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor[J]. Mol Cell Biol, 2000, 20(21): 8254-8263. doi: 10.1128/MCB.20.21.8254-8263.2000

  • McCormick C, Ganem D. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs[J]. Science, 2005, 307(5710): 739-741. doi: 10.1126/science.1105779

  • Means R E, Ishido S, Alvarez X. Multiple endocytic trafficking pathways of MHC class Ⅰ molecules induced by a Herpesvirus protein[J]. EMBO J, 2002, 21(7): 1638-1649. doi: 10.1093/emboj/21.7.1638

  • Moore P S, Boshoff C, Weiss R A. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV[J]. Science, 1996, 274(5293): 1739-1744. doi: 10.1126/science.274.5293.1739

  • Pati S, Cavrois M, Guo H G. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis[J]. J Virol, 2001, 75(18): 8660-8673. doi: 10.1128/JVI.75.18.8660-8673.2001

  • Poole L J, Zong J C, Ciufo D M. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end[J]. J Virol, 1999, 73(8): 6646-6660.

  • Polson A G, Wang D, DeRisi J. Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus[J]. Cancer Res, 2002, 62(15): 4525-4530.

  • Russo J J, Bohenzky R A, Chien M C. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)[J]. Proc Natl Acad Sci USA, 1996, 93(25): 14862-14867. doi: 10.1073/pnas.93.25.14862

  • Sarid R, Sato T, Bohenzky R A. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue[J]. Nat Med, 1997, 3(3): 293-298. doi: 10.1038/nm0397-293

  • Seo T, Lee D, Shim Y S. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpes-virus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death[J]. J Virol, 2002, 76(17): 8797-8807. doi: 10.1128/JVI.76.17.8797-8807.2002

  • Seo T, Park J, Choe J. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling[J]. Cancer Res, 2005, 65(5): 1738-1747. doi: 10.1158/0008-5472.CAN-04-2374

  • Soulier J, Grollet L, Oksenhendler E. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease[J]. Blood, 1995, 86(4): 1276-1280.

  • Spiller O B, Robinson M, O'Donnell E. Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein[J]. J Virol, 2003, 77(1): 592-599. doi: 10.1128/JVI.77.1.592-599.2003

  • Stine J T, Wood C, Hill M. KSHV-encoded CC chemokine vMIP-Ⅲ is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells[J]. Blood, 2000, 95(4): 1151-1157.

  • Sun Q, Zachariah S, Chaudhary P M. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation[J]. J Biol Chem, 2003, 278(52): 52437-52445. doi: 10.1074/jbc.M304199200

  • swanton c, mann d j, fleckenstein b. herpes viral cyclin/cdk6 complexes evade inhibition by cdk inhibitor proteins[J]. nature, 1997, 390(6656): 184-187. doi: 10.1038/36606

  • Tappero J W, Conant M A, Wolfe S F. Kaposi's sarcoma[J]. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol, 1993, 28(3): 371-395.

  • Viejo-Borbolla A, Ottinger M, Schulz T F. Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies[J]. Curr HIV /AIDS Rep, 2004, (1): 5-11.

  • Wang L, Wakisaka N, Tomlinson C C. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors[J]. Cancer Res, 2004, 64(8): 2774-2781. doi: 10.1158/0008-5472.CAN-03-3653

  • Wu F Y, Chen H, Wang S E. CCAAT/ enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21 (CIP-1) accumulation and G (1) cell cycle arrest during the Epstein-Barr virus lytic cycle[J]. J Virol, 2003, 77(2.): 1481-1500.

  • Yang T Y, Chen S C, Leach M W. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma[J]. J Exp Med, 2000, 191(3): 445-454. doi: 10.1084/jem.191.3.445